1. |
Kliment CR, Englert JM, Gochuico BR, et al. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem, 2009, 284(6): 3537-45.
|
2. |
史洪博, 卡德力亚, 赵丹. 抗Jo-1抗体、抗SSA/Ro52抗体阳性的多发性肌炎/皮肌炎临床特征分析. 检验医学与临床, 2021, 18(13): 1879-1882.
|
3. |
刘晓阳, 戴丽, 程洋. 多发性肌炎和皮肌炎相关间质性肺疾病的临床特征分析. 北京医学, 2022, 44(2): 108-113.
|
4. |
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med, 1975, 292(7): 344-347.
|
5. |
Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2013, 188(6): 733-748.
|
6. |
Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest, 1989, 96(1): 68-73.
|
7. |
Nakajima H, Harigai M, Hara M, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol, 2000, 27(5): 1164-1170.
|
8. |
He QR, Tang YF, Huang J, et al. The value of KL-6 in the diagnosis and assessment of interstitial lung disease. Am J Transl Res, 2021, 13(8): 9216-9223.
|
9. |
侯俊, 闫淯淳, 苏改秀, 等. 抗黑色素瘤分化相关基因蛋白5抗体与幼年皮肌炎间质性肺病严重程度的关系. 中华医学杂志, 2021, 101(33): 2606-2610.
|
10. |
Hu C, Wu C, Yang E, et al. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis. Clin Rheumatol, 2019, 38(8): 2181-2187.
|
11. |
刘玉梦, 许爱国, 赵玉苗, 等. 血清KL-6对多发性肌炎/皮肌炎合并肺部疾病的临床价值. 中国实用医刊, 2017, 44(10): 10-12.
|
12. |
Hanaoka M, Katsumata Y, Kawasumi H, et al. KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker. Mod Rheumatol, 2019, 29(4): 625-632.
|
13. |
吴雪, 武丽君, 罗采南等. 涎液化糖链抗原-6在结缔组织病相关间质性肺病诊断中的应用价值. 中华医学杂志, 2019, 99(40): 3172-3175.
|
14. |
Lee JS, Lee EY, Ha YJ, et al. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease. Arthritis Res Ther, 2019, 21(1): 58.
|
15. |
Rai M, Parthasarathi A, Beeraka NM, et al. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality. Cells, 2023, 12(9): 1281.
|
16. |
孙迪, 程哲, 蒋天赐, 等. 肺功能和KL-6在抗合成酶综合征相关间质性肺疾病与特发性肺纤维化中的特点及临床意义. 中华医学杂志, 2020, 100(10): 748-752.
|
17. |
Li T, Tang ZY, Zhang QB, et al. Clinical Characteristics and Risk Factors of Polymyositis and Dermatomyositis Combined with Interstitial Lung Disease in Patients Residing in the Northeast Sichuan Province of China. Curr Rheumatol Rev, 2023, 19(4): 455-462.
|